Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

RXST - RxSight Inc


IEX Last Trade
56.3
0.830   1.474%

Share volume: 426,702
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST

PREVIOUS CLOSE
CHG
CHG%

$55.47
0.83
1.50%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Performance
5 Days
-0.11%
1 Month
25.28%
3 Months
-5.26%
6 Months
0   0%
1 Year
94.05%
2 Year
355.86%
Key data
Stock price
$56.30
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$20.66 - $66.54
52 WEEK CHANGE
$0.93
MARKET CAP 
2.098 B
YIELD 
N/A
SHARES OUTSTANDING 
37.196 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
1.93
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$336,699
AVERAGE 30 VOLUME 
$554,802
Company detail
CEO:
Region: US
Website:
Employees: 267
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

calhoun vision is the world leader in adjustable intraocular lens technology. the company's proprietary technology utilizes light to enable surgeons to change the power of a lens after it has been implanted in the eye. this offers the potential to provide unparalleled visual outcomes and customization to the specific visual needs of each patient. calhoun vision's light adjustable lens technology is an investigational device in the united states and requires fda approval before it can be marketed commercially. the company has completed phases i and ii of the required clinical investigation; the third and final phase of study has commenced, and all subjects have been fully enrolled.

Recent news